The present study aims to estimating the prevalence of autoimmune thyroid disorders in Iraqi infertile women with polycystic ovary syndrome (PCOS). Eighty-five Iraqi women, with age range (19-45) years, were divided into three groups; first group included 33 women with PCOS; second group included 30 women without PCOS; while third group included 22 fertile women as controls. The clinical data [age, body mass index (BMI), and menstrual status] have been recorded. Blood samples were collected to determine the levels of reproductive hormones [estradiol (E2), luteinizing hormone (LH), and follicle stimulating hormone (FSH)]; and thyroid hormones [triiodothyronine (T3) and thyroxin (T4)]. Also, autoimmune thyroid antibodies assessment has been carried out to determine the titrations of anti-thyroid peroxidase antibody (Anti-TPO Ab) and anti-thyroglobulin antibody (Anti-TG Ab).The findings revealed that thepercentage of obese was significantly (P<0.01) higher in the women with PCOS and without PCOS (66.67% and 53.34%, respectively) compared with the control women (9.10%). Also, more of the infertile women with PCOS and without PCOS (51.51% and 46.67%, respectively) had oligomenorrhea. The results of hormonal analyses revealed that non-significant (P>0.05) differences were found in levels of E2 and FSH among the different groups. A significant (P<0.05) increase was recorded in level of LH among PCOS group compared with control and without PCOS groups. Also, LH/FSH ratio was increased significantly (P<0.05) in PCOS group compared with control and without PCOS groups. On the other hand, the results of thyroid hormones showed non-significant (P>0.05) differences for T3 and T4 levels among the studied groups. Autoimmune thyroid antibodies assessment showed a significant (P<0.05) increased in the Anti TPO Ab titration among the infertile women with and without PCOS compared with the control; while there was a non-significant (P>0.05) difference between infertile women with PCOS and without PCOS. A significant (P<0.05) increased in the Anti TG Ab titration was found among infertile women with and without PCOS compared with the control group; also, a significant (P<0.05) increased was found in the infertile women without PCOS compared to with PCOS. Correlation between autoimmune thyroid antibodies and the studied hormones in women with and without PCOS revealed only a significant (P<0.01) positive correlation between Anti-TPO Ab titration and LH level (r=0.26); while a non-significant correlation has been found between Anti-TG Ab titration and the studied hormones.
(1)
(1)
Background: Poly cystic ovary syndrome is a common disorder in women of reproductive age, it is associated with disturbance of reproductive, endocrine and metabolic functions. The pathophysiology of PCOS appears to be multifactorial and polygenic. Leptin seems to play an important role in pathophysiology of PCOS especially in women with BMI ≥25kg/m2. Objectives: To assess leptin level in both PCOS and healthy women and explore the relation to their body weight and body mass index. Patient and Methods: A total of 120 women were enrolled in this study, 60 women (50%) had PCOS (study group) and the reminder 60 women (50%) were healthy women and considered as control group. BMI was calculated first. Both groups were further sub
... Show More
(2)
(2)
Osteoporosis is a systemic disease of the skeleton, characterized by low bone mass and alteration in the micro-architecture of the bone tissue that lead to an increase in brittleness with the ensuing predisposition to bone fracture. Global statistics shows that women are more exposed to this disease than men and in particular at menopause. This study was designed to evaluate the use of some bone markers: serum osteocalcin (Ost), alkaline phosphatase (ALP), as bone formation markers, also parathyroid hormone (PTH), calcium and inorganic phosphate level, for the assessment of patients with osteoporosis and to evaluate their role in monitoring of several types of therapeutic interventions (such as bisphosphonates, hormonal replacement thera
... Show More
(1)
Background: Several studies suggested that skeletal system is adversely affected by diabetes and is associated with increased risk of osteoporosis and fragility fractures
Objectives: The study was a case-control study that designed to assess the level of bone turnover markers (BTMs) among patients with type 2 diabetes mellitus (T2DM) and to investigate the effect of body weight and diabetic control on the level of bone turnover
Type of the study: Cross- sectional study.
Methods: The present study included 100 postmenopausal women with type 2 diabetes mellitus. Sixty-six non-diabetic postmenopausal women were enrolled as a control. Fasting b
... Show More
Background: Preterm labor and related prematurity are predisposing factors that increase perinatal morbidity and mortality. Acute phase reactants are inflammatory markers which are positive and negative reactants explained by the reaction of reactants to the subclinical infection that are commonly associated with preterm labor. Objectives: To assess the role of acute phase reactants in pregnant women with preterm delivery. Patients and method: A case control study conducted in Gynecological Department of Baghdad Teaching Hospital from 1st February 2021 to 30th October 2021, on one hundred pregnant women with gestational age (28weeks - 36weeks+6days) who attended outpatient clinic; fifty pregnant women with established preterm labor
... Show More
Polycystic ovary syndrome (PCOS) referring to a syndrome that is recognized as a life-course disease and has both metabolic and reproductive signs; main pathophysiological cause includes insulin resistance, hyperandrogenism, and oxidative stress state. The study aimed to assess the impact of combining Myoinositol and Metformin, the main insulin-sensitizing drugs, on improving clinical, metabolic, and hormonal parameters in females with PCOS. A clinical trial that was prospective, randomized, and comparative on 54 patients (aged 18-40 y) are divided into three groups: group1 patients allocated to receive Myo-inositol(4g), group2 patients assigned to receive Metformin(1g) and group3 patients assigned to receive Myo-inositol(4g) + Metformin
... Show More
(1)
(2)